Published • loading... • Updated
GSK Invests 150m Euros in Clinical Laboratory in Walloon Brabant
Summary by belganewsagency.eu
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
GSK is investing 150 million euros in a new laboratory in Walloon Brabant. The pharmaceutical giant already has a significant presence in Wallonia with three major vaccine sites (Wavre, Rixensart, and Gembloux). GSK has approximately 9,000 employees in Belgium. Add to that numerous subcontractors, and so on. The new lab in Rixensart will complement existing operations. The goal of the lab is to accelerate the development of “vaccines of the futu…
·Antwerp, Belgium
Read Full Article
13:00 British GlaxoSmithKline, the largest pharmaceutical employer in our country with more than 8,500 employees, is investing 150 million euros in a new laboratory in Walloon Brabant to test vaccines under development. ‘...
·Belgium
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
